___

• Abou-Raya, S., Helmii, M., & Abou-Raya, A. (2009). Bone and mineral metabolism in older adults with Parkinson's disease. Age and Ageing, 38(6), 675-680.
• Buell, J. S., & Dawson-Hughes, B. (2008). Vitamin D and neurocognitive dysfunction: preventing “D” ecline? Molecular Aspects of Medicine, 29(6), 415-422.
• Butler, M. W., Burt, A., Edwards, T. L., Zuchner, S., Scott, W. K., Martin, E. R., Wang, L. (2011). Vitamin D receptor gene as a candidate gene for Parkinson disease. Annals of Human Genetics, 75(2), 201-210.
• Combs, B. L., & Cox, A. G. (2017). Update on the treatment of Parkinson’s disease psychosis: role of pimavanserin. Neuropsychiatric Disease and Treatment, 13, 737.
• de Jongh, R. T., van Schoor, N. M., & Lips, P. (2017). Changes in vitamin D endocrinology during aging in adults. Molecular and Cellular Endocrinology,453, 144-150
• Ding, H., Dhima, K., Lockhart, K. C., Locascio, J. J., Hoesing, A. N., Duong, K., Wills, A.-M. (2013). Unrecognized vitamin D3 deficiency is common in Parkinson disease Harvard Biomarker Study. Neurology, 81(17), 1531-1537.
• Dringen, R., Gutterer, J. M., & Hirrlinger, J. (2000). Glutathione metabolism in brain. The FEBS Journal, 267(16), 4912-4916.
• Ellis, J. M., & Fell, M. J. (2017). Current approaches to the treatment of Parkinson’s Disease. Bioorganic & Medicinal Chemistry Letters.
• Erro, R., Brigo, F., Tamburin, S., Zamboni, M., Antonini, A., & Tinazzi, M. (2017). Nutritional habits, risk, and progression of Parkinson disease. Journal of Neurology, 1-12.
• Evatt, M. L., DeLong, M. R., Khazai, N., Rosen, A., Triche, S., & Tangpricha, V. (2008). Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Archives of Neurology, 65(10), 1348-1352.
• Eyles, D. W., Smith, S., Kinobe, R., Hewison, M., & McGrath, J. J. (2005). Distribution of the vitamin D receptor and 1α-hydroxylase in human brain. Journal of Chemical Neuroanatomy, 29(1), 21-30.
• Garcion, E., Nataf, S., Berod, A., Darcy, F., & Brachet, P. (1997). 1, 25-Dihydroxyvitamin D 3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Molecular Brain Research, 45(2), 255-267. Garcion, E., Sindji, L., Leblondel, G., Brachet, P., & Darcy, F. (1999). 1, 25‐Dihydroxyvitamin D3 regulates the synthesis of γ‐glutamyl transpeptidase and glutathione levels in rat primary astrocytes. Journal of Neurochemistry, 73(2), 859-866.
• Garcion, E., Sindji, L., Montero‐Menei, C., Andre, C., Brachet, P., & Darcy, F. (1998). Expression of inducible nitric oxide synthase during rat brain inflammation: Regulation by 1, 25‐dihydroxyvitamin D3. Glia, 22(3), 282-294.
• Garcion, E., Wion-Barbot, N., Montero-Menei, C. N., Berger, F., & Wion, D. (2002). New clues about vitamin D functions in the nervous system. Trends in Endocrinology and Metabolism, 13(3), 100-105.
• Han, X., Xue, L., Li, Y., Chen, B., & Xie, A. (2012). Vitamin D receptor gene polymorphism and its association with Parkinson's disease in Chinese Han population. Neuroscience Letters, 525(1), 29-33.
• Henchcliffe, C., & Beal, M. F. (2008). Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nature clinical practice Neurology, 4(11), 600-609. Herrmann, M., Widmann, T., Colaianni, G., Colucci, S., Zallone, A., & Herrmann, W. (2005). Increased osteoclast activity in the presence of increased homocysteine concentrations. Clinical Chemistry, 51(12), 2348-2353.
• Kang, S. Y., Park, S., Oh, E., Park, J., Youn, J., Kim, J. S., . . . Jang, W. (2016). Vitamin D receptor polymorphisms and Parkinson’s disease in a Korean population: Revisited. Neuroscience Letters, 628, 230-235.
• Kenborg, L., Lassen, C. F., Ritz, B., Schernhammer, E. S., Hansen, J., Gatto, N. M., & Olsen, J. H. (2010). Outdoor work and risk for Parkinson9s disease: a population-based case–control study. Occupational and Environmental Medicine, oem. 2010.057448.
• Knekt, P., Kilkkinen, A., Rissanen, H., Marniemi, J., Sääksjärvi, K., & Heliövaara, M. (2010). Serum vitamin D and the risk of Parkinson disease. Archives of Neurology, 67(7), 808-811.
• Kosakai, A., Ito, D., Nihei, Y., Yamashita, S., Okada, Y., Takahashi, K., & Suzuki, N. (2011). Degeneration of mesencephalic dopaminergic neurons in klotho mouse related to vitamin D exposure. Brain Research, 1382, 109-117.
• Lin, A. M., Fan, S., Yang, D., Hsu, L., & Yang, C. (2003). Zinc-induced apoptosis in substantia nigra of rat brain: neuroprotection by vitamin D3. Free Radical Biology and Medicine, 34(11), 1416-1425.
• Lv, Z., Qi, H., Wang, L., Fan, X., Han, F., Wang, H., & Bi, S. (2014). Vitamin D status and Parkinson's disease: a systematic review and meta-analysis. Neurological Sciences, 35(11), 1723-1730. doi:10.1007/s10072-014-1821-6
• Miyake, Y., Tanaka, K., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., Kawamura, N. (2011). Lack of association of dairy food, calcium, and vitamin D intake with the risk of Parkinson’s disease: a case-control study in Japan. Parkinsonism & Related Disorders, 17(2), 112-116.
• Ozturk, E. A., Gundogdu, I., Tonuk, B., Kocer, B. G., Tombak, Y., Comoglu, S., & Cakci, A. (2016). Bone mass and vitamin D levels in Parkinson’s disease: is there any difference between genders? Journal of physical therapy science, 28(8), 2204-2209.
• Peterson, A. L. (2014). A review of vitamin D and Parkinson's disease. Maturitas, 78(1), 40-44.
• Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. (2014). The prevalence of Parkinson's disease: A systematic review and meta‐analysis. Movement Disorders, 29(13), 1583-1590.
• Puchacz, E., Stumpf, W. E., Stachowiak, E. K., & Stachowiak, M. K. (1996). Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Molecular Brain Research, 36(1), 193-196.
• Rimmelzwaan, L. M., van Schoor, N. M., Lips, P., Berendse, H. W., & Eekhoff, E. M. (2016). Systematic review of the relationship between vitamin D and Parkinson’s disease. Journal of Parkinson's Disease, 6(1), 29-37.
• Rizek, P., Niraj Kumar MD, D., & Jog, M. S. (2016). An update on the diagnosis and treatment of Parkinson disease. Canadian Medical Association. Journal, 188(16), 1157.
• Sato, Y., Iwamoto, J., & Honda, Y. (2011). Vitamin D deficiency-induced vertebral fractures may cause stooped posture in Parkinson disease. American Journal of Physical Medicine and Rehabilitation, 90(4), 281-286.
• Sato, Y., Kikuyama, M., & Oizumi, K. (1997). High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology, 49(5), 1273-1278. Shen, L., & Ji, H.-F. (2015). Associations between vitamin d status, supplementation, outdoor work and risk of parkinson’s disease: A meta-analysis assessment. Nutrients, 7(6), 4817-4827.
• Shinpo, K., Kikuchi, S., Sasaki, H., Moriwaka, F., & Tashiro, K. (2000). Effect of 1, 25‐dihydroxyvitamin D3 on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L‐buthionine sulfoximine and 1‐methyl‐4‐phenylpyridine. Journal of Neuroscience Research, 62(3), 374-382.
• Shrestha, S., Lutsey, P. L., Alonso, A., Huang, X., Mosley, T. H., & Chen, H. (2016). Serum 25‐hydroxyvitamin D concentrations in Mid‐adulthood and Parkinson's disease risk. Movement Disorders, 31(7), 972-978.
• Suzuki, M., Yoshioka, M., Hashimoto, M., Murakami, M., Noya, M., Takahashi, D., & Urashima, M. (2013). Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. The American journal of clinical nutrition, 97(5), 1004-1013.
• Török, R., Török, N., Szalardy, L., Plangar, I., Szolnoki, Z., Somogyvari, F., Klivenyi, P. (2013). Association of vitamin D receptor gene polymorphisms and Parkinson's disease in Hungarians. Neuroscience Letters, 551, 70-74.
• Van den Bos, F., Speelman, A., Van Nimwegen, M., van der Schouw, Y., Backx, F., Bloem, B., . . . Verhaar, H. (2013). Bone mineral density and vitamin D status in Parkinson’s disease patients. Journal of Neurology, 260(3), 754-760.
• Wang, J., Yang, D., Yu, Y., Shao, G., & Wang, Q. (2016). Vitamin D and sunlight exposure in newly-diagnosed Parkinson’s disease. Nutrients, 8(3), 142.
• Wang, L., Evatt, M. L., Maldonado, L. G., Perry, W. R., Ritchie, J. C., Beecham, G. W., Vance, J. M. (2015). Vitamin D from different sources is inversely associated with Parkinson disease. Movement Disorders, 30(4), 560-566. Zhang, Z.-T., He, Y.-C., Ma, X.-J., Li, D.-Y., & Lu, G.-C. (2014). Association between vitamin D receptor gene polymorphisms and susceptibility to Parkinson's disease: a meta-analysis. Neuroscience Letters, 578, 122-127.
• Zhu, D., Liu, G.-y., Lv, Z., Wen, S.-r., Bi, S., & Wang, W.-z. (2014). Inverse associations of outdoor activity and vitamin D intake with the risk of Parkinson’s disease. Journal of Zhejiang University. Science. B, 15(10), 923.